All Resources

November 03, 2025

Submission to the Government of Canada’s Consultation on the Review of the Canada – United States -Mexico Agreement

Learn more | View

Access to Medicine • October 28, 2025

2025 COST DRIVERS REPORT

Learn more | View

Drugs for Rare Diseases (DRD) • September 26, 2025

Rare Disease Framework for Alberta

This report is produced in English only….

Learn more | View

Access to Medicine • August 01, 2025

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget…

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • July 22, 2025

Reflections on a Potential Federal Drug Formulary: Medicines Industry Response to CDA Consultation

Learn more | View

Economic Impact • June 12, 2025

Open Letter

Learn more | View

Access to Medicine • March 10, 2025

Increasing Access to Innovative Medicines

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget…

Learn more | View

Private Drug Coverage • November 04, 2024

Issues and Opportunities to Modernize Private Drug Plan Sustainability 2024

Learn more | View

Patented Medicine Prices Review Board (PMPRB) • January 04, 2024

IMC Response to the PMPRB’s 2023 Scoping Paper for the Consultations on the Board’s Guidelines

Learn more | View

Access to Medicine • October 19, 2023

Cost Drivers Report 2023

Learn more | View

Private Drug Coverage • September 15, 2023

Cost of A Private Drug Plan Claim

Learn more | View

September 08, 2023

Submission on Consultation regarding Patent Term Adjustment (PTA) Regulations

Learn more | View